Pascussi J M, Drocourt L, Gerbal-Chaloin S, Fabre J M, Maurel P, Vilarem M J
INSERM CNRS, Route de Mende, Montpellier, France.
Eur J Biochem. 2001 Dec;268(24):6346-58. doi: 10.1046/j.0014-2956.2001.02540.x.
Although CYP3A induction by dexamethasone has been extensively documented, its mechanism is still unclear because both the role of the glucocorticoid receptor and the ability of dexamethasone to activate the human pregnane X receptor have been questioned. In an attempt to resolve this problem, we investigated the response of CYP3A4 to dexamethasone (10 nm-100 microm) in primary human hepatocytes and HepG2 cells, using a variety of methods: kinetic analysis of CYP3A4 and tyrosine aminotransferase expression, effects of RU486 and cycloheximide, ligand binding assay, cotransfection of HepG2 cells with CYP3A4 reporter gene constructs and vectors expressing the glucocorticoid receptor, pregnane X receptor or constitutively activated receptor. In contrast to rifampicin (monophasic induction), dexamethasone produces a biphasic induction of CYP3A4 mRNA consisting of a low-dexamethasone component (nmol concentrations) of low amplitude (factor of 3-4) followed by a high-dexamethasone component (supramicromolar concentrations) of high amplitude (factor of 15-30). We show that the low-dexamethasone component results from the glucocorticoid receptor-mediated expression of pregnane X receptor and/or constitutively activated receptor which, in turn, are able to transactivate CYP3A4 in a xenobiotic-independent manner. At supramicromolar concentrations (>10 microm), dexamethasone binds to and activates pregnane X receptor thus producing the high-dexamethasone component of CYP3A4 induction. We conclude that, in contrast to the other xenobiotic inducers of CYP3A4, glucocorticoids play a dual role in CYP3A4 expression, first by controlling the expression of PXR and CAR under physiological conditions (submicromolar concentrations) through the classical glucocorticoid receptor pathway, and second by activating the pregnane X receptor under bolus or stress conditions (supramicromolar concentrations).
尽管地塞米松对细胞色素P450 3A(CYP3A)的诱导作用已有大量文献记载,但其机制仍不清楚,因为糖皮质激素受体的作用以及地塞米松激活人孕烷X受体的能力均受到质疑。为了解决这个问题,我们采用多种方法研究了原代人肝细胞和HepG2细胞中CYP3A4对地塞米松(10 nM - 100 μM)的反应:CYP3A4和酪氨酸转氨酶表达的动力学分析、RU486和放线菌酮的作用、配体结合测定、HepG2细胞与CYP3A4报告基因构建体以及表达糖皮质激素受体、孕烷X受体或组成型激活受体的载体的共转染。与利福平(单相诱导)不同,地塞米松对CYP3A4 mRNA产生双相诱导,包括低幅度(3 - 4倍)的低地塞米松成分(纳摩尔浓度),随后是高幅度(15 - 30倍)的高地塞米松成分(超微摩尔浓度)。我们表明,低地塞米松成分源于糖皮质激素受体介导的孕烷X受体和/或组成型激活受体的表达,进而能够以不依赖于外源性物质的方式反式激活CYP3A4。在超微摩尔浓度(>10 μM)下,地塞米松与孕烷X受体结合并激活它,从而产生CYP3A4诱导的高地塞米松成分。我们得出结论,与其他CYP3A4的外源性诱导剂不同,糖皮质激素在CYP3A4表达中起双重作用,首先通过经典的糖皮质激素受体途径在生理条件下(亚微摩尔浓度)控制孕烷X受体(PXR)和组成型激活受体(CAR)的表达,其次在大剂量或应激条件下(超微摩尔浓度)激活孕烷X受体。